Funding to accelerate development of AI-driven tumour profiling tool OneMap More: One Biosciences raises €15 million to advance single-cell oncology platform Source: News
read moreThe U.K. is establishing a new biosecurity center designed to improve research into potentially pandemic-causing pathogens and protect against emerging public health threats. More: As US cuts research funding, UK plans to invest billions in new biosecurity center Source: fierce
read moreTaking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs directly to patients, Bristol Myers Squibb and Pfizer are doing the same with their mega-blockbuster blood thinner Eliquis. More:
read moreNovartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. More: Novartis’ Pluvicto finally picks up speed, delivers another trial win in early prostate cancer Source: fierce
read moreThe FDA is asking an expert panel to weigh in on “discordant results” from three randomized trials related to Lundbeck and Otsuka’s application for a Rexulti combination regimen in PTSD. More: For Lundbeck and Otsuka's PTSD filing, FDA questions Rexulti
read more
Healthinote rollout aims to improve early detection and patient self-management More: North East NHS launches digital platform to tackle chronic kidney disease Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals